ABSTRACT
O experimento foi conduzido com o objetivo de avaliar o efeito da suplementação de cromo-orgânico, sobre o desempenho, biometria dos órgãos digestivos e linfoides, histomoformetria da bolsa cloacal e rendimento de carcaça e cortes nobres de frangos de corte de 1 a 41 dias de idade, naturalmente submetidos a estresse por calor cíclico. Foram utilizados 400 pintos de corte da linhagem Cobb, em um delineamento experimental inteiramente casualizado, com cinco tratamentos: 0; 350; 700; 1050 e 1400 ppb de cromo na ração. Os valores do índice de temperatura de globo e umidade foram respectivamente, 83,39 e 80, para fase de crescimento e terminação. A suplementação do cromo orgânico influenciou (P 0,01) de forma quadrática a conversão alimentar dos animais segundo a equação Y=1,67-0,00016x+0,00000012x² (r² 0,976), na fase de 1 a 21 dias de idade. Os níveis de suplementação do cromo orgânico proporcionaram melhor índice de eficiência produtiva e maior percentual de parênquima cortical nas aves aos 21 dias. Na fase de 1 a 41 dias de idade, verificou-se que o peso de penas foi influenciado positivamente com os níveis de cromo orgânico e que não houve efeito para o desempenho dos frangos. Conclui-se que a suplementação da ração com cromo orgânico melhora desempenho e a resposta imune de frangos de corte frente a condições de estresse por calor.
This study was conducted to evaluate the effect of adding organic chromium dietary supplementation on performance, digestiveand lymphoid organs biometry and histomorphometry of the clocal bursa and on carcass and prime cuts performance of broilersfrom 1 to 41 days old, naturally stressed by heat cyclic. We used 400 chicks Cobb, the experimental design adopted was acompletely randomized, with five treatments: 0; 350; 700; 1050 and 1400 ppb chromium in diet. The supplementation withorganic chromium influenced (p<0,01) quadratic form on alimentary conversion the animals according to the equation Y = 1.67to 0.00016 x 0.00000012 x ² (r ² 0.976) in the period 1 to 21. The levels of supplementation of organic chromium improvementproductive efficiency and percentage of cortical parenchyma of broilers to 21 days. In phase to 1 from 41 days old, it was observedimprovement the feathers weight with levels of organic chromium, and there wasnt influence on performance of broilers. Thechromium in the organic form improves the performance of broiler chickens and immune response by broiler chickens in cyclic heat stress.
Subject(s)
Animals , Cloaca , Chromium Compounds/administration & dosage , Chromium/administration & dosage , Chickens , Animal Feed , Heat-Shock Response , Lymphatic System , Dietary SupplementsABSTRACT
With the purpose studying the effectivity of an intratumoral single dose of chromic [(32)P] phosphate with great particles for the treatment of solid tumors, studies of biolimination, biodistribution and therapeutic action were carried out. Only for comparative purpose, similar studies were undertaken using a solution of sodium [(32)P] orthophosphategelatine. The results show that when sodium [(32)P] orthophosphategelatine is used, the percentage of total elimination is (85.90+8,70) per cent with a higler percentage in urine (64.50+13.70) per cent than in faeces (21.40+4.50) per cent. In biodistribution studies, the greater percentage is found in bone (15.54+2.21) per cent while only a (2.51+0.39) per cent remains in the tumor. When great particles chromic [(32)P] phosphate was intratumorally injected, we determined that the total elimination is equal (36.28+6.27) per cent, finding a higler amount in faeces (29.44+5.26) per cent than in urine (6.84+2.21) per cent. Biodistribution studies demonstrated that (49.82+5.41) per cent remains in the tumor and (9.63+4.89) per cent of the injected activity is found in the liver. On the other hand, when therapeutic action was evoluted, we observed that the percentage of tumor regression (P.T.R) is 52.0 per cent for the tumors injected with chromic [(32)P] phosphate and 0.0 per cent for those injected with sodium [(32)P] orthophosphate-gelatine. These results show that the great particles colloid of chromic [(32)P] phosphate is not safe enough for the tratment of solid tumors, since it is mobilezed from the injection point, delivering a high dose to the whole organism.